Lunit Announces Completion of Volpara Acquisition to Advance AI-driven Cancer Care
Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of its acquisition of Volpara Health Technologies Ltd., a global developer of medical software for breast cancer screening. The landmark acquisition was completed in an eight-month timeline, and will advance cancer diagnostics and care, according to the Seoul, South Korea-based company.
Source: itnonline.com